Showing results (271-280 of 498) with videos related to

Sort By:
Pageof 50
Structure (London, England : 1993)|June 22, 2026
Multifaceted effects of N-glycosylation on amyloidogenic κ light chains in AL amyloidosisSarita Puri, Valentina Speranzini, Monica Russo, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 30, 2015
Novel mitochondrial protein interactors of immunoglobulin light chains causing heart amyloidosisFrancesca Lavatelli, Esther Imperlini, Stefania Orrù, et al.
British Journal of Haematology|June 2, 2020
Challenges in the management of patients with systemic light chain (AL) amyloidosis during the COVID-19 pandemicEfstathios Kastritis, Ashutosh Wechalekar, Stefan Schönland, et al.
American Journal of Hematology|July 27, 2005
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004Morie A Gertz, Ray Comenzo, Rodney H Falk, et al.
Protein Science : a Publication of the Protein Society|January 24, 2007
Lysine 58-cleaved beta2-microglobulin is not detectable by 2D electrophoresis in ex vivo amyloid fibrils of two patients affected by dialysis-related amyloidosisSofia Giorgetti, Monica Stoppini, Glenys A Tennent, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 22, 2015
Vascular alterations in apolipoprotein A-I amyloidosis (Leu75Pro). A case-control studyMaria Lorenza Muiesan, Massimo Salvetti, Anna Paini, et al.
Elife|March 3, 2025
A conformational fingerprint for amyloidogenic light chainsCristina Paissoni, Sarita Puri, Luca Broggini, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|February 13, 2023
Impact of cytogenetic abnormalities on treatment outcomes in patients with amyloid light-chain amyloidosis: subanalyses from the ANDROMEDA studyShaji Kumar, Angela Dispenzieri, Divaya Bhutani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2012
New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomesGiovanni Palladini, Angela Dispenzieri, Morie A Gertz, et al.
Molecules (Basel, Switzerland)|April 3, 2021
Clinical Amyloid Typing by Proteomics: Performance Evaluation and Data Sharing Between Two CentresDiana Canetti, Francesca Brambilla, Nigel B Rendell, et al.
Pageof 50